| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/24/2011 | EP1369106B1 Emulsion composition |
| 08/24/2011 | CN1929816B Pharmaceutical compositions comprising midazolam in a high concentration |
| 08/24/2011 | CN1688295B Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers |
| 08/24/2011 | CN1404389B Timed pulsatile drug delivery systems |
| 08/24/2011 | CN102164943A Method for preserving polypeptides using a sugar and polyethyleneimine |
| 08/24/2011 | CN102164618A Non-viral compositions and methods for transfecting gut cells in vivo |
| 08/24/2011 | CN102164617A Compositions and methods for achieving sustained therapeutic drug concentrations in a subject |
| 08/24/2011 | CN102164616A Anti-angiogenic compounds |
| 08/24/2011 | CN102164615A Drug sustained release agent, adsorbent, functional food, mask, and adsorptive sheet |
| 08/24/2011 | CN102164606A Light-stabilized pharmaceutical composition |
| 08/24/2011 | CN102164586A Oral preparation |
| 08/24/2011 | CN102164581A Pharmaceutical composition |
| 08/24/2011 | CN102164579A Liquid formulations of bendamustine |
| 08/24/2011 | CN102161984A Method for isolating tetramer uric acid oxydiazing enzyme |
| 08/24/2011 | CN102161754A Functional modification method for branched polyethylene glycol (PEG) derivative |
| 08/24/2011 | CN102161752A Process method for synthesizing medical biodegradable polylactic acid by polycondensation of lactic acid in presence of creatinine catalyst |
| 08/24/2011 | CN102161712A Method for preparing micromolecule pectin |
| 08/24/2011 | CN102161688A Cholesterol-structure-fragment-containing biocompatible synthesis liposomes as well as preparation method and application thereof |
| 08/24/2011 | CN102160894A Benzamide analog mediated brain-targeting delivery system |
| 08/24/2011 | CN102160860A Medicament for promoting hair growth and preventing hair loss and preparation method thereof |
| 08/24/2011 | CN102160858A Edible film and manufacturing method thereof |
| 08/24/2011 | CN102160857A Methylphenidate patch |
| 08/24/2011 | CN102160856A Neglect-proof drinking immunization tablet for infectious bursal disease (IBD) and preparation method thereof |
| 08/24/2011 | CN102160855A Dex-ibuprofen sustained release tablets and preparation method thereof |
| 08/24/2011 | CN102160854A Cyclodextrin-included florfenicol quick-release water-soluble powder preparation and preparation method thereof |
| 08/24/2011 | CN102160853A Vinpocetine injection and preparation method thereof |
| 08/24/2011 | CN102160852A Ibuprofen injection and preparation method thereof |
| 08/24/2011 | CN102160851A Ibuprofen injection and preparation method thereof |
| 08/24/2011 | CN101829190B Dandeng Tongnao tablets and preparation process thereof |
| 08/24/2011 | CN101721382B Lansoprazole submicron emulsion solid preparation and novel application thereof |
| 08/24/2011 | CN101711743B Febuxostat dry suspension and preparation method thereof |
| 08/24/2011 | CN101708247B Compound antivirus immune intensifier of Chinese herbal medicine |
| 08/24/2011 | CN101693022B Method for preparing resveratrol sustained-release capsule capable of preventing rheumatoid arthritis |
| 08/24/2011 | CN101670068B Medicament for treating gonarthromeningitis and preparation technology thereof |
| 08/24/2011 | CN101642433B Nimesulide liposome solid preparation and preparation method of drug composite thereof |
| 08/24/2011 | CN101579313B Cefalexin liposome and medicinal composition thereof |
| 08/24/2011 | CN101564380B Method for preparing magnetic liposome |
| 08/24/2011 | CN101371917B Brain protein hydrolysate sodium chloride injection |
| 08/24/2011 | CN101366702B Orally taken or buccal antiviral medicament-Ribavirin tablet and method of preparing the same |
| 08/24/2011 | CN101352494B Children's granules for clearing heat and suppressing cough and preparation method thereof |
| 08/24/2011 | CN101298501B High polymer nano-particle containing carboxyl, preparation and use thereof |
| 08/24/2011 | CN101204447B Anti-hepatitis-jaundice soft capsule and preparation method thereof |
| 08/24/2011 | CN101204446B Soft capsule containing medicine for acute and chronic hepatitis |
| 08/24/2011 | CN101199602B Containing medicament soft capsule for treating gynecology disease and preparing method thereof |
| 08/24/2011 | CN101190288B Sustained-release oral traditional Chinese medicine preparation for treating gastric ulcer and preparation method thereof |
| 08/24/2011 | CN101148520B Temperature sensitive chitosan hydrogel |
| 08/24/2011 | CN101141948B Drug delivery compositions and related methods |
| 08/24/2011 | CN101102751B Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 08/23/2011 | US8003782 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| 08/23/2011 | US8003742 Polymer derivatives with proximal reactive groups |
| 08/23/2011 | US8003734 Vectors for inserting nucleic acid into cells |
| 08/23/2011 | US8003706 Enhanced production of blood clotting factors and fibrin fabric |
| 08/23/2011 | US8003705 Biocompatible hydrogels made with small molecule precursors |
| 08/23/2011 | US8003697 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 08/23/2011 | US8003690 Topical nanoparticulate spironolactone formulation |
| 08/23/2011 | US8003595 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 08/23/2011 | US8003389 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 08/23/2011 | US8003323 Reduction in bacterial colonization by administering bacteriophage compositions |
| 08/23/2011 | US8003129 Enhanced transport using membrane disruptive agents |
| 08/23/2011 | US8003125 Crosslinked polyethylene glycol, a derivative thereof, or a copolymer; controlled release of a drug |
| 08/23/2011 | US8003115 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 08/23/2011 | US8003094 Combination with a solvent, skin buffer and antioxidant to improve solubility and bioavailability for a variety of dosage forms |
| 08/23/2011 | US8003089 Y shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates |
| 08/23/2011 | CA2729518A1 Multiplication of the efficacy of anti-infectious agents by a composition comprising an extract made from dehydrated and partially sodium-free seawater |
| 08/23/2011 | CA2708452A1 Multiplication of the efficacy of anti-infectious agents by a composition further comprising a dispersing agent together with a metal activiating agent |
| 08/23/2011 | CA2623306C Oral vehicle for systemic pharmaceuticals |
| 08/23/2011 | CA2527646C Abuse resistant amphetamine compounds |
| 08/23/2011 | CA2502986C Cosmetic and pharmaceutical foam |
| 08/23/2011 | CA2484070C Antibacterial compositions comprising metal phthalocyanine analogues |
| 08/23/2011 | CA2468845C Stabilized reverse micelle compositions and uses thereof |
| 08/23/2011 | CA2463690C Granules containing acid-unstable chemical in large amount |
| 08/23/2011 | CA2462276C 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 08/23/2011 | CA2456076C Integrin inhibitors for the treatment of eye diseases |
| 08/23/2011 | CA2449954C Dry powder inhalation system for transpulmonary administration |
| 08/23/2011 | CA2442159C Treatment using neublastin polypeptides |
| 08/23/2011 | CA2415414C Particulate vectors for improving oral absorption of active principles |
| 08/23/2011 | CA2358107C Shelf-stable formulation of glucagon-like peptide-1 |
| 08/23/2011 | CA2348926C Methods and compositions for the prevention of tolerance to medications |
| 08/23/2011 | CA2336138C Polymers for delivering nitric oxide in vivo |
| 08/23/2011 | CA2216098C Protein formulation comprising coagulation factor viii or factor ix in an aqueous solution |
| 08/18/2011 | WO2011100469A1 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute |
| 08/18/2011 | WO2011100267A1 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom |
| 08/18/2011 | WO2011100234A2 Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods |
| 08/18/2011 | WO2011100131A2 Monomers and oligonucleotides comprising cycloaddition adduct(s) |
| 08/18/2011 | WO2011099998A2 Edible compositions |
| 08/18/2011 | WO2011099872A1 Methods for improving sperm functionality |
| 08/18/2011 | WO2011099601A1 Particulate medicinal composition |
| 08/18/2011 | WO2011099573A1 Extended release preparation |
| 08/18/2011 | WO2011099526A1 Hydrogen-containing hypotonic biocompatible solution |
| 08/18/2011 | WO2011098962A2 Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer |
| 08/18/2011 | WO2011098829A1 Nucleic acid complexes |
| 08/18/2011 | WO2011098552A2 Methods and compositions for the preparation of aerosols |
| 08/18/2011 | WO2011098518A2 Delivery of immunoglobulin variable domains and constructs thereof |
| 08/18/2011 | WO2011098407A1 Microspheres |
| 08/18/2011 | WO2011098400A1 Igf-i poly (ethylene glycol) conjugates |
| 08/18/2011 | WO2011098285A2 Dermatological, pharmaceutical composition suitable for oligonucleotides |
| 08/18/2011 | WO2011077402A3 Amphiphilic polymer functionalised by methionine |
| 08/18/2011 | WO2011075500A3 Clostridium botulinum carrier complex for the administration of therapeutic agents |
| 08/18/2011 | WO2011050039A3 Modular functional peptides for the intracellular delivery of nanoparticles |
| 08/18/2011 | WO2011049960A9 Compositions and methods for the treatment of sinonasal disorders |